Medtronic Pulmonary Vein Ablation Catheter(R) GOLD (PVAC GOLD) 990078 - Product Usage: The Pulmonary Vein Ablation Catheter GOLD is designed to be used for the creation of endocardial lesions (focal and linear) during cardiac ablation procedures for the treatment of symptomatic Atrial Fibrillation (AF). The PVAC GOLD is also intended to be used for cardiac electrophysiological (EP) mapping of pulmonary vein potentials, delivery of diagnostic pacing stimuli and verifying electrical isolation of the pulmonary veins post-treatment.
Published April 3, 2019 · Recall initiated: March 4, 2019
Summary
FDA records medical device Class III recall Z-1069-2019, published April 3, 2019 and initiated March 4, 2019. Recalling firm: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF); Status: Ongoing; Reported quantity: 2917 units; Lot: UDI 00643169522572 All lot numbers distributed in the past eighteen (18) months and all newly manufactured without the updated IFU are affected until product with the updated Instruction for Use (IFU) is available. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The firm issued an updated instructions for use to reduce the potential for phrenic nerve injury.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
- Distributor
- International distribution in the countries of Australia, Austria, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Netherlands, Poland, Portugal, Spain, Switzerland, United Kingdom.
- Lot
- UDI 00643169522572 All lot numbers distributed in the past eighteen (18) months and all newly manufactured without the updated IFU are affected until product with the updated Instruction for Use (IFU) is available.
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACRT-D DTBA1D1 VIVA XT IS1/DF1 US, Model Number DTBA1D1; Implantable Cardioverter DefibrillatorsJune 28, 2023
- FDACRTD DTMC2QQ COMPIA MRI QUAD OUS DF4, Model Number DTMC2QQ; Implantable Cardioverter DefibrillatorsJune 28, 2023
- FDAICD CROME VR MRI IS1 DF1, Model Number DVPC3D1; Implantable Cardioverter DefibrillatorsJune 28, 2023
- FDAICD-VR DVME3D4 MIRRO MRI, Model Number DVME3D4; Implantable Cardioverter DefibrillatorsJune 28, 2023
- FDACleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed byApril 10, 2019
- FDAPaltop Fully Guided Surgical Kit- containing the 1.25mm Hex Driver For surgical and restorative applicationsApril 3, 2019
Questions about this recall
Was Medtronic Pulmonary Vein Ablation Catheter(R) GOLD (PVAC GOLD) 990078 - Product Usage: The Pulmonary Vein Ablation Catheter GOLD is designed to be used for the creation of endocardial lesions (focal and linear) during cardiac ablation procedures for the treatment of symptomatic Atrial Fibrillation (AF). The PVAC GOLD is also intended to be used for cardiac electrophysiological (EP) mapping of pulmonary vein potentials, delivery of diagnostic pacing stimuli and verifying electrical isolation of the pulmonary veins post-treatment. recalled?
Yes. FDA published recall Z-1069-2019 on April 3, 2019. Reported hazard: The firm issued an updated instructions for use to reduce the potential for phrenic nerve injury.
What should I do if I have this product?
Voluntary: Firm initiated · Letter